SS
Steve Seedhouse Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
6.9%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
96.4%
Neutral
3.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $26 |
282%
upside
| 2 | -8.8% |
0
%
| 15 Oct ‘25 5 days ago |
|
|
|
Overweight
Assumed
| $40 |
161%
upside
| 1 | +30% |
0
%
| 6 Oct ‘25 14 days ago |
|
|
|
Overweight
Initiated
| $7 |
122%
upside
| 1 | +5.8% |
0
%
| 2 Oct ‘25 18 days ago |
|
|
|
Market Perform
Downgraded
| – | – | 2 | +50% |
0
%
| 19 Sep ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $49 |
305%
upside
| 2 | +56% |
0
%
| 17 Sep ‘25 1 month ago |
|
|
|
Outperform
Reiterated
| $63 |
77%
upside
| 2 | +9.4% |
0
%
| 9 Sep ‘25 1 month ago |
|
|
|
Strong Buy
Maintained
| $147 |
217%
upside
| 3 | +31% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Strong Buy
Maintained
| $82 |
13%
upside
| 2 | +27% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $40 |
49%
upside
| 1 | +19% |
0
%
| 1 Aug ‘25 2 months ago |
|
|
|
Overweight
Initiated
| $26 |
51%
upside
| 1 | -9.7% |
0
%
| 11 Jul ‘25 3 months ago |
|
|
|
Overweight
Initiated
| $52 |
727%
upside
| 1 | -72% |
0
%
| 11 Jul ‘25 3 months ago |
|
|
|
Overweight
Initiated
| $76 |
82%
upside
| 1 | +32% |
0
%
| 11 Jul ‘25 3 months ago |
|
|
|
Overweight
Initiated
| $10 |
29%
upside
| 1 | +13% |
0
%
| 29 Apr ‘25 5 months ago |
|
|
|
Overweight
Initiated
| $28 |
21%
upside
| 1 | +34% |
0
%
| 29 Apr ‘25 5 months ago |
|
|
|
Overweight
Initiated
| $10 |
700%
upside
| 1 | +2.5% |
0
%
| 29 Apr ‘25 5 months ago |
|
|
|
Overweight
Initiated
| $104 |
207%
upside
| 3 | -11% |
0
%
| 28 Apr ‘25 5 months ago |
|
|
|
Outperform
Downgraded
| $22 |
565%
upside
| 2 | -68% |
0
%
| 11 Dec ‘24 10 months ago |
|
|
|
Strong Buy
Upgraded
| $14 |
373%
upside
| 1 | -10% |
0
%
| 29 Oct ‘24 11 months ago |
|